Latest News in Pharma industry - CTOL Digital Solutions

Latest News in Pharma industry

6 hours ago

Eli Lilly's Daily Weight Loss Pill Succeeds in Major Trial, Clearing Path for First Needle-Free Alternative to Popular Injections

AbbVie Acquires 90-Minute Psychedelic Depression Treatment for $1.2 Billion

20 hours ago

AbbVie Acquires 90-Minute Psychedelic Depression Treatment for $1.2 Billion

Eli Lilly Issues Rare 40-Year Bonds as Long-Term Corporate Debt Nearly Disappears from Markets

8 days ago

Eli Lilly Issues Rare 40-Year Bonds as Long-Term Corporate Debt Nearly Disappears from Markets

FDA Approves First Drug Treatment for Rare Throat Disease That Previously Required Repeated Surgery

11 days ago

FDA Approves First Drug Treatment for Rare Throat Disease That Previously Required Repeated Surgery

FDA Approves First Treatment for Lung Disease That Left 500,000 Americans Without Options

14 days ago

FDA Approves First Treatment for Lung Disease That Left 500,000 Americans Without Options

Genmab's New Therapy Slashes Lymphoma Progression Risk by 79% in Global Trial

19 days ago

Genmab's New Therapy Slashes Lymphoma Progression Risk by 79% in Global Trial

Novo Nordisk Senior Director's Internal Email Exposes Management Problems Behind Stock Crash

22 days ago

Novo Nordisk Senior Director's Internal Email Exposes Management Problems Behind Stock Crash

Mounjaro Diabetes Drug Shows 16% Lower Death Rate in Phase 3 Heart Study Against Trulicity

26 days ago

Mounjaro Diabetes Drug Shows 16% Lower Death Rate in Phase 3 Heart Study Against Trulicity

Novo Nordisk Loses $42 Billion in Market Value After 21% Stock Drop on Profit Warning

28 days ago

Novo Nordisk Loses $42 Billion in Market Value After 21% Stock Drop on Profit Warning

Eli Lilly Acquires Verve Therapeutics for $1.3 Billion to Develop One-Time Heart Disease Treatments

32 days ago

Eli Lilly Acquires Verve Therapeutics for $1.3 Billion to Develop One-Time Heart Disease Treatments

ImageneBio Launches on Nasdaq Following Merger, Raises $75M for Skin Treatment Development

32 days ago

ImageneBio Launches on Nasdaq Following Merger, Raises $75M for Skin Treatment Development

Abivax Raises $650M at Premium Price After Strong Ulcerative Colitis Drug Results

33 days ago

Abivax Raises $650M at Premium Price After Strong Ulcerative Colitis Drug Results

SEC Probe Sends Telix Stock Down 15% Even as Company Reports 63% Revenue Growth

34 days ago

SEC Probe Sends Telix Stock Down 15% Even as Company Reports 63% Revenue Growth

MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset

34 days ago

MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset

Third Death Sends Sarepta's Gene Therapy Empire Crumbling

38 days ago

Third Death Sends Sarepta's Gene Therapy Empire Crumbling

National Cancer Institute Launches Major Study of Guardant's Multi-Cancer Blood Test

42 days ago

National Cancer Institute Launches Major Study of Guardant's Multi-Cancer Blood Test

Ascendis Pharma's New Hypoparathyroidism Drug Frees 96% of Patients From Traditional Treatment in Landmark 3-Year Study

42 days ago

Ascendis Pharma's New Hypoparathyroidism Drug Frees 96% of Patients From Traditional Treatment in Landmark 3-Year Study

Merck Launches Final Trials for Monthly HIV Prevention Pill with Gates Foundation Support

43 days ago

Merck Launches Final Trials for Monthly HIV Prevention Pill with Gates Foundation Support

In Bold Respiratory Play, Merck Bets $10 Billion on Verona's Revolutionary COPD Treatment

48 days ago

In Bold Respiratory Play, Merck Bets $10 Billion on Verona's Revolutionary COPD Treatment

Centivax Raises $45M Series A to Advance Universal Flu Vaccine to Human Trials

48 days ago

Centivax Raises $45M Series A to Advance Universal Flu Vaccine to Human Trials

Proxy Giants Hand Sinovac's Board Lifeline as $10 Billion Battle Reaches Breaking Point

50 days ago

Proxy Giants Hand Sinovac's Board Lifeline as $10 Billion Battle Reaches Breaking Point

Pharmaceutical Reshoring Continues - Hikma's $1 Billion Bet on American Medicine

57 days ago

Pharmaceutical Reshoring Continues - Hikma's $1 Billion Bet on American Medicine

A Breakthrough in the Storm - FDA Approves First Treatment for Deadly Inflammatory Condition

59 days ago

A Breakthrough in the Storm - FDA Approves First Treatment for Deadly Inflammatory Condition

Breaking Ground in Addiction Medicine - Achieve Life Sciences' FDA Application Signals First New Smoking Cessation Drug in Two Decades

60 days ago

Breaking Ground in Addiction Medicine - Achieve Life Sciences' FDA Application Signals First New Smoking Cessation Drug in Two Decades

Pancreatic Cancer Drug Market Set for Threefold Surge as Innovation Pipeline Swells

63 days ago

Pancreatic Cancer Drug Market Set for Threefold Surge as Innovation Pipeline Swells

Actuate Therapeutics Drug Extends Pancreatic Cancer Survival by 4 Months in Phase 2 Trial

63 days ago

Actuate Therapeutics Drug Extends Pancreatic Cancer Survival by 4 Months in Phase 2 Trial

Novo Nordisk Terminates Hims & Hers Deal Amid Weight-Loss Drug Compounding Controversy

64 days ago

Novo Nordisk Terminates Hims & Hers Deal Amid Weight-Loss Drug Compounding Controversy

Eli Lilly's Weekly Insulin Matches Daily Treatments in Major Clinical Trials

64 days ago

Eli Lilly's Weekly Insulin Matches Daily Treatments in Major Clinical Trials

Novo Nordisk's Higher-Dose Wegovy Delivers 21% Weight Loss in Phase 3 Trial, Matching Surgical Results

64 days ago

Novo Nordisk's Higher-Dose Wegovy Delivers 21% Weight Loss in Phase 3 Trial, Matching Surgical Results

Exelixis Drug Combination Extends Survival in Phase 3 Advanced Colorectal Cancer Trial

64 days ago

Exelixis Drug Combination Extends Survival in Phase 3 Advanced Colorectal Cancer Trial

Novo Nordisk Advances Promising Weight Loss Drug Amycretin to Final Testing Stage After Strong Trial Results

66 days ago

Novo Nordisk Advances Promising Weight Loss Drug Amycretin to Final Testing Stage After Strong Trial Results

FDA Grants Medicovestor's Pancreatic Cancer Drug Special Status as Treatment Shows Promise

70 days ago

FDA Grants Medicovestor's Pancreatic Cancer Drug Special Status as Treatment Shows Promise

AI Drug Discovery Firm Insilico Medicine Raises $110M and Reaches $1 Billion Valuation

71 days ago

AI Drug Discovery Firm Insilico Medicine Raises $110M and Reaches $1 Billion Valuation

Dupixent Outperforms Xolair in Groundbreaking EVEREST Trial for Nasal Polyps and Asthma Treatment

72 days ago

Dupixent Outperforms Xolair in Groundbreaking EVEREST Trial for Nasal Polyps and Asthma Treatment

AstraZeneca Signs $5.3 Billion AI Drug Discovery Deal with Chinese Firm CSPC

74 days ago

AstraZeneca Signs $5.3 Billion AI Drug Discovery Deal with Chinese Firm CSPC

FDA Approves Moderna's RSV Vaccine for Younger At-Risk Adults Aged 18-59

74 days ago

FDA Approves Moderna's RSV Vaccine for Younger At-Risk Adults Aged 18-59

J&J's New Leukemia Drug Shows 90% Response Rate in Early Trials

75 days ago

J&J's New Leukemia Drug Shows 90% Response Rate in Early Trials

FDA Approves Nuvation Bio's New Lung Cancer Drug IBTROZI With 90% Response Rate

76 days ago

FDA Approves Nuvation Bio's New Lung Cancer Drug IBTROZI With 90% Response Rate

Novo Nordisk Invests $812 Million in AI Drug Discovery Deal for New Obesity Treatment

76 days ago

Novo Nordisk Invests $812 Million in AI Drug Discovery Deal for New Obesity Treatment

Samsung Bioepis Partners with NIPRO to Bring Multiple Biosimilars to Japanese Market

78 days ago

Samsung Bioepis Partners with NIPRO to Bring Multiple Biosimilars to Japanese Market

Rare Kidney Disease Patients See Hope as EMPAVELI Maintains Strong Results After One Year

81 days ago

Rare Kidney Disease Patients See Hope as EMPAVELI Maintains Strong Results After One Year

Roche's New Room-Temperature SMA Tablet Wins European Approval, Expanding Treatment Access

83 days ago

Roche's New Room-Temperature SMA Tablet Wins European Approval, Expanding Treatment Access

Bristol Myers Squibb Commits $11.1 Billion to Partner with BioNTech on Dual-Target Cancer Drug

85 days ago

Bristol Myers Squibb Commits $11.1 Billion to Partner with BioNTech on Dual-Target Cancer Drug

AstraZeneca's IMFINZI Reduces Gastric Cancer Recurrence Risk by 29% in Landmark Trial

85 days ago

AstraZeneca's IMFINZI Reduces Gastric Cancer Recurrence Risk by 29% in Landmark Trial

Biohaven's New Kidney Disease Drug Shows 81% Reduction in Key Disease Marker During Early Testing

89 days ago

Biohaven's New Kidney Disease Drug Shows 81% Reduction in Key Disease Marker During Early Testing

Rocket Pharma Stock Plunges 62.8% After Patient Death Halts Gene Therapy Trial

90 days ago

Rocket Pharma Stock Plunges 62.8% After Patient Death Halts Gene Therapy Trial

Lilly's $1 Billion Bet on Pain - Acquisition Targets the Next Frontier in Non-Opioid Treatment

91 days ago

Lilly's $1 Billion Bet on Pain - Acquisition Targets the Next Frontier in Non-Opioid Treatment

China's Mazdutide Weight Loss Drug Shows 15% Effectiveness in Major Medical Journal Study

92 days ago

China's Mazdutide Weight Loss Drug Shows 15% Effectiveness in Major Medical Journal Study

SpringWorks' NF1 Drug Mirdametinib Wins European Regulator Support for Adults and Children

93 days ago

SpringWorks' NF1 Drug Mirdametinib Wins European Regulator Support for Adults and Children

Countdown to Cash Crisis - The High-Stakes Proxy War at MediPharm Labs

95 days ago

Countdown to Cash Crisis - The High-Stakes Proxy War at MediPharm Labs

Load More

We use cookies on our website to enable certain functions, to provide more relevant information to you and to optimize your experience on our website. Further information can be found in our Privacy Policy and our Terms of Service . Mandatory information can be found in the legal notice